|
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) |
|
Lexicon Pharmaceuticals Inc
LXRX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Lexicon Pharmaceuticals Inc growth rates, revenue grew
by 980.25 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 162
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.72 %
Lexicon Pharmaceuticals Inc net loss increased from $-51 millions, to $-65 millions in III. Quarter 2024,
• More on LXRX's Growth
|
|
Lexicon Pharmaceuticals Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 20.22 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 51.73.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on LXRX's Valuation
|
|
|
|
|
Lexicon Pharmaceuticals Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 20.22 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 51.73.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
Lexicon Pharmaceuticals Inc Price to Book Ratio is at 1.52 lower than Industry Avg. of 81.16. and higher than S&P 500 Avg. of 0.01
• More on LXRX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com